These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2707062)
1. Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection. Yew WW; Kwan SY; Ma WK; Aung-khin M; Mok CK Chest; 1989 May; 95(5):1051-5. PubMed ID: 2707062 [TBL] [Abstract][Full Text] [Related]
2. Single daily-dose ofloxacin monotherapy for Mycobacterium fortuitum sternotomy infection. Yew WW; Kwan SY; Ma WK; Khin MA; Mok CK Chest; 1989 Nov; 96(5):1150-2. PubMed ID: 2805845 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from postoperative sternotomy wounds. Yew WW; Kwan SY; Ma WK; Lui KS; Aung MK Clin Ther; 1989; 11(6):775-85. PubMed ID: 2611821 [TBL] [Abstract][Full Text] [Related]
4. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. Wallace RJ; Swenson JM; Silcox VA; Bullen MG J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667 [TBL] [Abstract][Full Text] [Related]
5. Ofloxacin therapy of Mycobacterium fortuitum infection: further experience. Yew WW; Kwan SY; Ma WK; Lui KS; Suen HC J Antimicrob Chemother; 1990 May; 25(5):880-1. PubMed ID: 2373673 [No Abstract] [Full Text] [Related]
6. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum. Tsui SY; Yew WW; Li MS; Chan CY; Cheng AF Antimicrob Agents Chemother; 1993 May; 37(5):1001-3. PubMed ID: 8517688 [TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Dalovisio JR; Pankey GA; Wallace RJ; Jones DB Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterium fortuitum infections of the mediastinum. Sethi GK; Simons WJ; Scott SM J Cardiovasc Surg (Torino); 1985; 26(3):307-9. PubMed ID: 3997975 [TBL] [Abstract][Full Text] [Related]
11. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study. Ghosh R; Das S; De A; Kela H; Saha ML; Maiti PK Int J Mycobacteriol; 2017; 6(1):34-37. PubMed ID: 28317802 [TBL] [Abstract][Full Text] [Related]
13. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Wallace RJ; Bedsole G; Sumter G; Sanders CV; Steele LC; Brown BA; Smith J; Graham DR Antimicrob Agents Chemother; 1990 Jan; 34(1):65-70. PubMed ID: 2327761 [TBL] [Abstract][Full Text] [Related]
14. Mycobacterium fortuitum wound infection following laparoscopy. Sethi S; Sharma M; Ray P; Singh M; Gupta A Indian J Med Res; 2001 Mar; 113():83-4. PubMed ID: 11525156 [TBL] [Abstract][Full Text] [Related]
15. Determination of the in vitro susceptibility of 220 Mycobacterium fortuitum isolates to ten antimicrobial agents. Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A J Chemother; 1995 Dec; 7(6):503-8. PubMed ID: 8667033 [TBL] [Abstract][Full Text] [Related]